Mar 4, 2021
|
Data Supporting Use of Predictive Enrichment Markers for Lumos Pharma’s LUM-201 Therapy in Clinical Trials for Moderate PGHD Published in Journal of the Endocrine Society
|
|
Mar 2, 2021
|
Lumos Pharma to Present Poster Demonstrating Greater GH Response to LUM-201 than to Standard GH Secretagogues in PGHD at the Endocrine Society (ENDO) 2021 Annual Meeting
|
|
Feb 22, 2021
|
Lumos Pharma to Report Full Year 2020 Financial Results and Host Conference Call on March 9, 2021
|
|
Feb 16, 2021
|
Lumos Pharma Announces Changes to its Board of Directors
|
|